Moleculin Biotech Inc.

(NASDAQ: MBRX) Trade

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Moleculin Biotech Inc is a clinical-stage pharmaceutical company. The firm focus on the development of oncology drug candidates. The drug technologies used by the company are anthracycline, a portfolio of STAT3 inhibitors, and collection of inhibitors of glycolysis.

Contact Information

Website: www.moleculin.com
Email: mbrx@lythampartners.com
Main Phone: +1 713 300-5160
Address: 5300 Memorial Drive
Address 2: Suite 950
State: TX
City / Town: Houston
Country: US
Postal Code: 77007

Issuer Information

Exchange: NSC
CEO: Walter V. Klemp
Employees: 15
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A